Medicare Advantage
  
  
  
  
  
  
  
  
  
  
  
  
MPattachmentdataPub
  
96be5992-c930-4727-8f3a-78ffc0ba90ec.aspx
  
2588Repository Corticotropin (H.P. Acthar® Gel Injection)Pharmacy (08)MA08.067aMA08.06796be5992-c930-4727-8f3a-78ffc0ba90ecRepository Corticotropin (H.P. Acthar® Gel Injection)Repository Corticotropin (H.P. Acthar® Gel Injection)4/23/2021 9:00 AM
2b33f9cb-8a07-41b9-bd6a-f1cacb404a86.aspx
  
2589Teprotumumab(Tepezza™)MA08.115Pharmacy (08)MA08.115MA08.1152b33f9cb-8a07-41b9-bd6a-f1cacb404a86Teprotumumab (Tepezza™)Teprotumumab (Tepezza™)4/23/2021 10:00 AM
5/24/2021
80047361-f007-4716-85aa-dcdc78e1c1f1.aspx
  
2509LipectomyandLiposuctionMA11.070bSurgery (11)MA11.070bMA11.07080047361-f007-4716-85aa-dcdc78e1c1f1Lipectomy and LiposuctionLipectomy and Liposuction3/30/2021 2:00 PM
6/28/2021
cf10c7b8-b8c4-4c50-b092-b3fd9b426af0.aspx
  
2558Experimental/InvestigationalServicesMA00.005zAdministrative (00)MA00.005zMA00.005cf10c7b8-b8c4-4c50-b092-b3fd9b426af0Experimental/Investigational ServicesExperimental/Investigational Services4/12/2021 12:00 PM
{"2559": {"Id":2559,"MPAttachmentLetter":"C","Title":"Experimental/Investigational services with a specific Current Procedural Terminology (CPT) or Healthcare Common Procedure Coding System (HCPCS) Code, that are reported for other services.","MPPolicyAttachmentInternalSourceId":5384,"PolicyAttachmentPageName":"3b9c2856-ab9d-48e1-b543-a7fd9ff40f3c"},"2560": {"Id":2560,"MPAttachmentLetter":"B","Title":"Experimental/Investigational Services without a Specific Current Procedural Terminology (CPT) or Healthcare Common Procedure Coding System (HCPCS) Code.","MPPolicyAttachmentInternalSourceId":5385,"PolicyAttachmentPageName":"c9c50371-62dc-49ec-bbac-8fe808613212"},"2561": {"Id":2561,"MPAttachmentLetter":"A","Title":"Experimental/Investigational Services Represented by a Specific Current Procedural Terminology (CPT) or Healthcare Common Procedure Coding System (HCPCS) Code.","MPPolicyAttachmentInternalSourceId":5386,"PolicyAttachmentPageName":"c7af35d0-cf7c-4019-82eb-dac18b492917"},}
7/12/2021
01c28084-1be3-475b-a144-ab8946ecb516.aspx
  
2631Inebilizumab-cdon(Uplizna)MA08.126bPharmacy (08)MA08.126bMA08.12601c28084-1be3-475b-a144-ab8946ecb516Inebilizumab-cdon (Uplizna)Inebilizumab-cdon (Uplizna)5/11/2021 1:00 PM
8/9/2021